Sheri Shamblin
Director
Pfizer
Sheri Shamblin is a Director at Pfizer Worldwide Development and Research and leads a group of formulation scientists that design and develop clinical and commercial oral formulations. She has over 25 years of experience in the pharmaceutical industry that includes preclinical and late-stage development, with expertise in novel modified release formulations, and strategies for overcoming poor solubility that include salt formation and amorphous solid dispersions. Sheri has published over 30 research articles, served as an Adjunct Professor at Purdue University School of Pharmacy and lecturer at Connecticut College Department of Chemistry. In addition, she is a Member of the Advisory Board for the Zeeh Pharmaceutical Station at The University of Wisconsin-Madison Wisconsin and in 2020 was a Nominee for Connecticut Women of Innovation.